The Oregon Biz Report - Business News from Oregon

Read about accutane journal moderate acne here

Supreme Court denies overtime to certain sales reps

June 28, 2012

Supreme Court agrees with Ninth Circuit that drug company representatives are ‘salesmen’
Ater Wynne LLP
NW Law frim

Last week the Supreme Court affirmed a decision of the Ninth Circuit holding that pharmaceutical sales representatives are not entitled to overtime under the Fair Labor Standards Act because they are covered by the FLSA’s “outside sales” exemption. In Christopher v. SmithKline, the Court issued a 5-4 decision, with the majority reasoning that “[the representatives were] hired for their sales experience. They were trained to close each sales call by obtaining the maximum commitment possible from the physician. They worked away from the office, with minimal supervision, and they were rewarded for their efforts with incentive compensation.”

The dissent agreed with the Obama administration that the “outside sales” exemption does not apply to pharmaceutical sales representatives because the representatives do not actually sell the drugs. Writing for the dissenters, Justice Stephen G. Breyer wrote, “At most [the sales representative] obtains from the doctor a ‘nonbinding commitment’ to advise his patient to take the drug (or perhaps a generic equivalent) as well as to write any necessary prescription.”

See our earlier coverage of Christoper v. SmithKline here.

  
Print This Post Print This Post    Email This Post Email This Post

Discuss this article

no comments yet

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Articles

Press Releases



Top Business News

 

Top Women's News

 

Top Natural Resource News

 

Top Faith News

 

Copyright © 2016, OregonReport. All Rights Reserved. | Terms of Use - Copyright - Legal Policy | Contact Oregon Report

Stay Tuned...

Stay up to date with the latest political news and commentary from Oregon Business Report through daily email updates:

Delivered by FeedBurner

Prefer another subscription option? Subscribe to our RSS Feed, become a fan on Facebook, or follow us on Twitter.

RSS Twitter Facebook

No Thanks (close this box)